Concepedia

Benli Su

BS

Statistics

Publications

5

Citations

707

H-Index

5

Active since

2005

Affiliations

Dalian Medical University(Current)

Second Affiliated Hospital of Dalian Medical University

Liaoning Normal University

Benli Su is an author at Dalian Medical University specializing in molecular oncology, molecular biology, and oncology.

Publications per year

2005–2019

5

Publications

5

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

, , +10

shRNA-mediated knockdown of Bmi-1 inhibit lung adenocarcinoma cell migration and metastasis

Xiuxiang Meng, Yifang Wang, Xiangyu Zheng et al. · Lung Cancer · 2012 · 39 citations

, , +10

Antisense RNA-Mediated Suppression of Bmi-1 Gene Expression Inhibits the Proliferation of Lung Cancer Cell Line A549

Yu Qi, Benli Su, Dandan Liu et al. · Oligonucleotides · 2007 · 25 citations

, , +16

Effect of siRNA‐mediated silencing of Bmi‐1 gene expression on HeLa cells

Yue Jiang, Benli Su, Xiuxiang Meng et al. · Cancer Science · 2009 · 20 citations · Full text

, , +12

Construction of antisense Bmi-1 expression plasmid and its inhibitory effect on K562 cells proliferation.

Xiuxiang Meng, Weihong Liu, Dandan Liu et al. · PubMed · 2005 · 11 citations

, , +16

1–5 of 5